U.S. Markets open in 1 hr 38 mins

Can The Uptrend Continue for Cymabay Therapeutics (CBAY)?

Zacks Equity Research

Investors certainly have to be happy with Cymabay Therapeutics, Inc. CBAY and its short term performance. After all, the stock has jumped by 19.1% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. This is certainly a good trend, but investors are probably asking themselves, can this positive trend continue for CBAY?

While we can never know for sure, it is pretty encouraging that estimates for CBAY have moved higher in the past few weeks, meaning that analyst sentiment is moving in the right way. Plus, the stock actually has a Zacks Rank #1 (Strong Buy), so the recent move higher for this spotlighted company may definitely continue over the next few weeks. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Best Place to Start Your Stock Search

Today, you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buy" stocks – absolutely free of charge. Since 1988, Zacks Rank #1 stocks have nearly tripled the market, with average gains of +26% per year. Plus, you can access the list of portfolio-killing Zacks Rank #5 "Strong Sells" and other private research.See these stocks free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CymaBay Therapeutics Inc. (CBAY): Free Stock Analysis Report
To read this article on Zacks.com click here.